Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese

Hepatology Research

Volumn 38, Issue 7, 2008, Pages 689-695

  Umemura, Takeji ^a   Ota, Masao ^a   Yoshizawa, Kaname ^a   Katsuyama, Yoshihiko ^a   Ichijo, Tetsuya ^a   Tanaka, Eiji ^a   Kiyosawa, Kendo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoimmune hepatitis; CTLA4; Genetic susceptibility; SNPs

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR4 ANTIGEN;

3' UNTRANSLATED REGION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN TISSUE; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TYPE 1 AUTOIMMUNE HEPATITIS;

EID: 44649177081     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00337.x     Document Type: Article

References (31)

1. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354: 54-66.
2. Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology 2006; 43: S132-44.
3. Czaja AJ, Bianchi FB, Carpenter HA et al. Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology 2005; 41: 207-15.
4. Doherty DG, Donaldson PT, Underhill JA et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 1994; 19: 609-15.
5. Strettell MD, Donaldson PT, Thomson LJ et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 1997; 112: 2028-35.
6. Czaja AJ, Strettell MD, Thomson LJ et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 1997; 25: 317-23.
7. Seki T, Ota M, Furuta S et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992; 103: 1041-7.
8. Yoshizawa K, Ota M, Katsuyama Y et al. Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis. J Hepatol 2005; 42: 578-84.
9. Donaldson PT. Genetics in autoimmune hepatitis. Semin Liver Dis 2002; 22: 353-64.
10. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3: 541-7.
11. Finck BK, Linsley PS, Wofsy D. Treatment of murine lupus with CTLA4Ig. Science 1994; 265: 1225-7.
12. Kremer JM, Dougados M, Emery P et al. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005; 52: 2263-71.
13. Genovese MC, Becker J-C, Schiff M et al. Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor {alpha} Inhibition. N Engl J Med 2005; 353: 1114-23.
14. Kremer JM, Genant HK, Moreland LW et al. Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis: A Randomized Trial. Ann Intern Med 2006; 144: 865-76.
15. Agarwal K, Czaja AJ. Jones DE, Donaldson PT. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 2000; 31: 49-53.
16. Bittencourt PL, Palacios SA, Cancado EL et al. Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am J Gastroenterol 2003; 98: 1616-20.
17. Ueda H, Howson JM, Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-11.
18. Umemura T, Ota M, Hamano H et al. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol (in press).
19. Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
20. Umemura T, Ota M, Yoshizawa K et al. Lack of association between FCRL3 and FcgammaRII polymorphisms in Japanese type 1 autoimmune hepatitis. Clin Immunol 2007; 122: 338-42.
21. Vergani D, Alvarez F, Bianchi FB et al. Liver autoimmune serology: A consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004; 41: 677-83.
22. Umemura T, Alter HJ, Tanaka E et al. SEN virus: Response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C. Hepatology 2002; 35: 953-9.
23. Umemura T, Wang RY, Schechterly C, Shih JW, Kiyosawa K, Alter HJ. Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C. Hepatology 2006; 43: 91-9.
24. Umemura T, Tanaka E, Ostapowicz G et al. Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. J Infect Dis 2003; 188: 1545-52.
25. Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K. Immunoglobin G4-hepatopathy: Association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007; 46: 463-71.
26. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
27. Umemura T, Ota M, Hamano H, Katsuyama Y, Kiyosawa K, Kawa S. Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut 2006; 55: 1367-8.
28. Ota M, Seki T, Nomura N et al. Modified PCR-RFLP method for HLA-DPB1 and - DQA1 genotyping. Tissue Antigens 1991; 38: 60-71.
29. Longhi MS, Hussain MJ, Mitry RR et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006; 176: 4484-91.
30. Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D. Impairment of CD4(+) CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 2004; 41: 31-7.
31. Longhi MS, Ma Y, Mitry RR et al. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 2005; 25: 63-71.